BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16969313)

  • 1. [Hepatitis C in prison settings: screening and therapy are improving. Comparative survey between 2000 and 2003].
    Remy AJ;
    Presse Med; 2006 Sep; 35(9 Pt 1):1249-54. PubMed ID: 16969313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
    Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
    Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy.
    Semaille C; Le Strat Y; Chiron E; Chemlal K; Valantin MA; Serre P; Caté L; Barbier C; Jauffret-Roustide M;
    Euro Surveill; 2013 Jul; 18(28):. PubMed ID: 23870097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
    Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
    Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus Elimination Program among Prison Inmates, Israel.
    Eisen L; Mor Z; Madar M; Rabinovitch R; Dadon Y; Sheffer R; Kaliner E; Goldstein L
    Emerg Infect Dis; 2023 Nov; 29(11):2358-2361. PubMed ID: 37877627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
    Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
    Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening and treatment of hepatitis C virus in prisons: 10 years of experience].
    Werling K; Makara M; Nemesi K; Horváth G; Schneider F; Bali I; Enyedi J; Jancsik V; Káfony A; Lesch M; Lombay B; Müller Z; Ozsvár Z; Patai Á; Péterfi Z; Pusztay M; Szabó O; Szlávik J; Tóth T; Varga M; Gács J; Újhelyi E; Nemes Nagy A
    Orv Hetil; 2022 May; 163(22):871-878. PubMed ID: 35895613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
    Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
    J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
    Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
    Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
    PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
    Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
    Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of HBV and HCV infections and incidence of HCV infection after 3, 6 and 12 months detention in La Santé prison, Paris].
    Arrada A; Zak Dit Zbar O; Vasseur V
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():6-8. PubMed ID: 11965092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV micro-elimination in two prisons in Milan, Italy: A model of care.
    Giuliani R; Casigliani V; Fornili M; Sebastiani T; Freo E; Arzilli G; Scardina G; Baglietto L; Tavoschi L; Ranieri R
    J Viral Hepat; 2020 Dec; 27(12):1444-1454. PubMed ID: 32815623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
    Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
    J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.
    Schulte B; Stöver H; Thane K; Schreiter C; Gansefort D; Reimer J
    Int J Prison Health; 2009; 5(1):39-44. PubMed ID: 25758928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
    Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
    J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A framework for management of hepatitis C in prisons.
    Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
    Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prisons and HCV: a review and a report on an experience in New South Wales Australia.
    Batey RG; Jones T; McAllister C
    Int J Prison Health; 2008; 4(3):156-63. PubMed ID: 18698530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.